Form D · Biotechnology
SUNDANCE DIAGNOSTICS, INC.
Boulder, CO · CIK 0001568961
Offering snapshot reported May 19, 2015 · SEC filing
- Reported sold
- $5.51K Offering amount: $6.6K
- Investors reported
- 56 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 30, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 19, 2015 | Initial | $5,513 | No comparison | 56 | SEC filing |
| Oct 29, 2014 | Amendment | $1,553 | -$1,386vs Oct 28, 2014 | 7 | SEC filing |
| Oct 28, 2014 | Amendment | $2,939 | $1,939vs Mar 4, 2013 | 41 | SEC filing |
| Mar 4, 2013 | Amendment | $1,000 | No comparison | 13 | SEC filing |
| Mar 1, 2013 | Initial | Yet to sell | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240180
Source: Form D, filed May 19, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kim Bechthold | Director, Executive |
| Wayne H Bechthold | Executive |
| Allan Ogilvie | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2525 Arapahoe Avenue Suite E4 553
Boulder, CO, 80302
Boulder, CO, 80302